Sunday, November 27, 2011

Sanzinc




Sanzinc may be available in the countries listed below.


Ingredient matches for Sanzinc



Zinc Sulfate

Zinc Sulfate monohydrate (a derivative of Zinc Sulfate) is reported as an ingredient of Sanzinc in the following countries:


  • Japan

International Drug Name Search

Saturday, November 26, 2011

Respigam


Generic Name: respiratory syncytial virus immune globulin, human (Intravenous route)


RES-pi-ra-tor-ee sin-SISH-al VYE-rus i-MUNE GLOB-ue-lin, HUE-man


Commonly used brand name(s)

In the U.S.


  • Respigam

Available Dosage Forms:


  • Solution

Therapeutic Class: Immune Serum


Uses For Respigam


Respiratory syncytial virus immune globulin intravenous (RSV-IGIV) belongs to a group of medicines known as immunizing agents. RSV-IGIV is used to prevent infection caused by respiratory syncytial virus (RSV). RSV-IGIV works by giving your body the antibodies it needs to protect it against RSV infection.


RSV infection can cause serious problems, such as pneumonia and bronchitis, which affect the lungs; and in severe cases, even death. These problems are more likely to occur in infants and young children less than 6 months of age with chronic lung disease, those born with heart problems, and those with a history of premature birth.


Onset of RSV activity usually occurs in November and continues through April or early May, with peak activity occurring from late January through mid-February. A good way to help prevent RSV infection is to get RSV-IGIV before the start of the RSV season.


RSV-IGIV is used to prevent serious lower respiratory tract infection caused by the respiratory syncytial virus (RSV) in children less than 24 months of age with breathing problems or a history of premature birth.


RSV-IGIV is to be administered only by or under the supervision of your doctor or other health care professional.


Before Using Respigam


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Children 24 months of age and older: Use is not recommended. Use is not recommended in children born with chronic heart disease. Also, too much fluid in the body is more likely to occur in infants and children with underlying lung disease.


Geriatric


RSV-IGIV has been tested only in infants and young children less than 24 months of age and there is no specific information about its use in older patients.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.


Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Allergic reaction to human immunoglobulins or

  • Immunoglobulin A (IgA) deficiencies—RSV-IGIV may cause severe reactions

Proper Use of Respigam


Make certain your health care professional knows if you are on any special diet, such as low-sodium or low-sugar diet.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For injection dosage form:
    • For preventing respiratory syncytial virus (RSV) infection:
      • Adults and children 24 months of age and older—Use is not recommended.

      • Infants and children younger than 24 months of age—750 milligrams (mg) per kilogram (kg) (340.9 mg per pound) of body weight injected into a vein once a month for five months.



Respigam Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


Rare
  • Difficulty in breathing and swallowing

  • hives

  • itching, especially of feet and hands

  • reddening of skin, especially around ears

  • swelling of eyes, face, or inside of nose

  • unusual tiredness or weakness, sudden and severe

  • fever of 39.2 °C (102.6 °F) or higher

  • increased heart rate

  • vomiting

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Respigam side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Respigam resources


  • Respigam Side Effects (in more detail)
  • Respigam Use in Pregnancy & Breastfeeding
  • Respigam Drug Interactions
  • Respigam Support Group
  • 0 Reviews for Respigam - Add your own review/rating


  • Respigam injectable Concise Consumer Information (Cerner Multum)

  • RespiGam MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Respigam with other medications


  • Respiratory Syncytial Virus

Friday, November 25, 2011

Molsidomin dura




Molsidomin dura may be available in the countries listed below.


Ingredient matches for Molsidomin dura



Molsidomine

Molsidomine is reported as an ingredient of Molsidomin dura in the following countries:


  • Germany

International Drug Name Search

Sunday, November 20, 2011

Lusadeina




Lusadeina may be available in the countries listed below.


Ingredient matches for Lusadeina



Codeine

Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Lusadeina in the following countries:


  • Peru

Paracetamol

Paracetamol is reported as an ingredient of Lusadeina in the following countries:


  • Peru

International Drug Name Search

Cozaarex




Cozaarex may be available in the countries listed below.


Ingredient matches for Cozaarex



Losartan

Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Cozaarex in the following countries:


  • Argentina

International Drug Name Search

Wednesday, November 16, 2011

Hipnolam




Hipnolam may be available in the countries listed below.


Ingredient matches for Hipnolam



Propofol

Propofol is reported as an ingredient of Hipnolam in the following countries:


  • Peru

International Drug Name Search

Tuesday, November 15, 2011

Lipazym




Lipazym may be available in the countries listed below.


Ingredient matches for Lipazym



Pancreatin

Pancreatin is reported as an ingredient of Lipazym in the following countries:


  • Germany

International Drug Name Search

Monday, November 14, 2011

Betadine Alcohol




Betadine Alcohol may be available in the countries listed below.


Ingredient matches for Betadine Alcohol



Povidone Iodine

Povidone-Iodine is reported as an ingredient of Betadine Alcohol in the following countries:


  • New Zealand

International Drug Name Search

Saturday, November 5, 2011

Sevoness




Sevoness may be available in the countries listed below.


Ingredient matches for Sevoness



Sevoflurane

Sevoflurane is reported as an ingredient of Sevoness in the following countries:


  • Japan

International Drug Name Search

Thursday, November 3, 2011

Doctors Foster and Smith Chlorhexidine Cloth





Dosage Form: FOR ANIMAL USE ONLY

DIRECTIONS


Clean affected area thoroughly. Apply pad to affected area 2 to 3 times daily or as directed by your veterinarian. Let product dry, then area may be covered or bandaged.



CAUTION


For external use only. Avoid contact with eyes. Consult your veterinarian in cases of deep or puncture wounds, animal bites, serious burns or if redness and irritation persists or increases.



ACTIVE INGREDIENT


0.5% Chlorhexidine Diacetate



OTHER INGREDIENTS


Aloe Vera Gel, Bitter Extractives, Boric Acid, Fragrance, Glycerin, Isopropyl Alcohol, Propylene Glycol, Water.



STORAGE


Keep tightly closed at room temperature.



For animal use only.


Keep out of reach of children and pets to prevent accidental ingestion.



Doctors


Foster and Smith


Veterinarian Formulated


Septi-Soothe


Pads


Gentle, Antiseptic Formula


90 Pads










DOCTORS FOSTER AND SMITH  
chlorhexidine  cloth










Product Information
Product TypeOTC ANIMAL DRUGNDC Product Code (Source)65713-908
Route of AdministrationTOPICALDEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CHLORHEXIDINE (CHLORHEXIDINE)CHLORHEXIDINE0.052 g  in 104 g
















Inactive Ingredients
Ingredient NameStrength
ALOE VERA LEAF 
BORIC ACID 
GLYCERIN 
ISOPROPYL ALCOHOL 
PROPYLENE GLYCOL 
WATER 


















Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains      










Packaging
#NDCPackage DescriptionMultilevel Packaging
165713-908-05104 g In 1 JARNone










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other01/01/2000


Labeler - Doctors Foster and Smith (122135148)

Registrant - United Pet Group (931135730)









Establishment
NameAddressID/FEIOperations
JUNGLE LABORATORIES CORPORATION032615270manufacture
Revised: 03/2010Doctors Foster and Smith



Wednesday, November 2, 2011

Diabetic Siltussin DAS-Na



Generic Name: guaifenesin (Oral route)

gwye-FEN-e-sin

Commonly used brand name(s)

In the U.S.


  • Allfen

  • Altarussin

  • Amibid LA

  • Antitussin

  • Bidex 400

  • Diabetic Siltussin DAS-Na

  • Diabetic Tussin EX

  • Drituss G

  • Guaifenex G

  • Guaifenex LA

  • Mucinex

  • Robitussin

In Canada


  • Benylin-E

  • Benylin E Extra Strength Chest Congestion

  • Broncho-Grippex Expectorant

  • Robitussin Extra Strength

Available Dosage Forms:


  • Tablet, Extended Release

  • Solution

  • Capsule, Extended Release

  • Packet

  • Liquid

  • Tablet

  • Capsule

  • Elixir

  • Syrup

Therapeutic Class: Expectorant


Uses For Diabetic Siltussin DAS-Na


Guaifenesin is used to help clear mucus or phlegm (pronounced flem) from the chest when you have congestion from a cold or flu. It works by thinning the mucus or phlegm in the lungs.


This medicine is available both over-the-counter (OTC) and with your doctor's prescription.


Do not give any over-the-counter (OTC) cough and cold medicine to a baby or child under 4 years of age. Using these medicines in very young children might cause serious or possibly life-threatening side effects .


Before Using Diabetic Siltussin DAS-Na


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Although there is no specific information comparing use of guaifenesin in children with use in other age groups, this medicine is not expected to cause different side effects or problems in children than it does in adults. However, check with your doctor before using this medicine in children who have a chronic cough, such as occurs with asthma, or who have an unusually large amount of mucus or phlegm with the cough. Children with these conditions may need a different kind of medicine. Also, guaifenesin should not be given to children and infants younger than 2 years of age unless you are directed to do so by your doctor.


Do not give any over-the-counter (OTC) cough and cold medicine to a baby or child under 4 years of age. Using these medicines in very young children might cause serious or possibly life-threatening side effects .


Geriatric


Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults. Although there is no specific information comparing use of guaifenesin in the elderly with use in other age groups, this medicine is not expected to cause different side effects or problems in older people than it does in younger adults.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.


Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Proper Use of guaifenesin

This section provides information on the proper use of a number of products that contain guaifenesin. It may not be specific to Diabetic Siltussin DAS-Na. Please read with care.


Drinking plenty of water while taking guaifenesin may help loosen mucus or phlegm in the lungs.


For patients taking the extended-release capsule form of this medicine:


  • Swallow the capsule whole, or open the capsule and sprinkle the contents on soft food such as applesauce, jelly, or pudding and swallow without crushing or chewing.

For patients taking the extended-release tablet form of this medicine:


  • If the tablet has a groove in it, you may carefully break it into two pieces along the groove. Then swallow the pieces whole, without crushing or chewing them.

  • If the tablet does not have a groove, it must be swallowed whole. Do not break, crush, or chew it before swallowing.

Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For regular (short-acting) oral dosage forms (capsules, oral solution, syrup, or tablets):
    • For cough:
      • Adults—200 to 400 milligrams (mg) every four hours.

      • Children 6 to 12 years of age—100 to 200 mg every four hours.

      • Children 4 to 6 years of age—50 to 100 mg every four hours.

      • Children and infants up to 4 years of age—Use is not recommended .



  • For long-acting oral dosage forms (extended-release capsules or tablets):
    • For cough:
      • Adults—600 to 1200 mg every twelve hours.

      • Children 6 to 12 years of age—600 mg every twelve hours.

      • Children 4 to 6 years of age—300 mg every twelve hours.

      • Children and infants up to 4 years of age—Use is not recommended .



Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Precautions While Using Diabetic Siltussin DAS-Na


If your cough has not improved after 7 days or if you have a fever, skin rash, continuing headache, or sore throat with the cough, check with your doctor. These signs may mean that you have other medical problems.


Diabetic Siltussin DAS-Na Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Less common or rare
  • Diarrhea

  • dizziness

  • headache

  • hives

  • nausea or vomiting

  • skin rash

  • stomach pain

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Diabetic Siltussin DAS-Na side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Diabetic Siltussin DAS-Na resources


  • Diabetic Siltussin DAS-Na Side Effects (in more detail)
  • Diabetic Siltussin DAS-Na Use in Pregnancy & Breastfeeding
  • Drug Images
  • Diabetic Siltussin DAS-Na Support Group
  • 51 Reviews for Diabetic Siltussin DAS-Na - Add your own review/rating


Compare Diabetic Siltussin DAS-Na with other medications


  • Bronchitis
  • Cough
  • Fibromyalgia

Tuesday, November 1, 2011

Liparex




Liparex may be available in the countries listed below.


Ingredient matches for Liparex



Atorvastatin

Atorvastatin calcium (a derivative of Atorvastatin) is reported as an ingredient of Liparex in the following countries:


  • Argentina

International Drug Name Search